4-(1-Methyl-1H-pyrazol-4-yl)benzaldehyde

Catalog No. :
ACIHGE314
CAS No. :
179055-29-9
Molecular Formula :
C11H10N2O
Molecular Weight :
186.21

IUPAC Name:4-(1-methyl-1H-pyrazol-4-yl)benzaldehyde

4-(1-Methyl-1H-pyrazol-4-yl)benzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$101.00Login to see priceIn stockIn stock
250mg97%$171.00Login to see priceIn stockIn stock
1g97%$403.00Login to see priceIn stockInquiry
5g97%$1992.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1-Methyl-1H-pyrazol-4-yl)benzaldehyde
IUPAC Name4-(1-methyl-1H-pyrazol-4-yl)benzaldehyde
MDL No.MFCD08669908
Molecular FormulaC11H10N2O
Molecular Weight186.21
SMILESO=CC1=CC=C(C2=CN(C)N=C2)C=C1
InChI KeyAUZCPJSYHVZKQZ-UHFFFAOYSA-N
Synonym4-(1-METHYL-1H-PYRAZOL-4-YL)BENZALDEHYDE;Benzaldehyde,4-(1-methyl-1H-pyrazol-4-yl)-;4-(1-methylpyrazol-4-yl)benzaldehyde
CAS No.179055-29-9
PubChem CID10821404

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIHGE314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGPLR128 route compound structure diagram
    ACGPLR1281122-91-4 In Stock
  4. Then
  5. ACIHGE314 route product structure diagram
    ACIHGE314179055-29-9 In Stock
Inquiry

2. ACIHGE314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGPLR128 route compound structure diagram
    ACGPLR1281122-91-4 In Stock
  4. Then
  5. ACIHGE314 route product structure diagram
    ACIHGE314179055-29-9 In Stock
Inquiry

Comments (0)